The threat of antimalarial drug resistance

[1]  Elizabeth A. Winzeler,et al.  Antimalarial drug discovery — approaches and progress towards new medicines , 2017, Nature Reviews Microbiology.

[2]  F. Nosten,et al.  Single Low Dose Primaquine (0.25mg/kg) Does Not Cause Clinically Significant Haemolysis in G6PD Deficient Subjects , 2016, PloS one.

[3]  Hannah C. Slater,et al.  Assessing the potential impact of artemisinin and partner drug resistance in sub-Saharan Africa , 2016, Malaria Journal.

[4]  F. Nosten,et al.  A Brief History of Qinghaosu , 2015, Trends in parasitology.

[5]  N. Speybroeck,et al.  Confirmed Plasmodium vivax Resistance to Chloroquine in Central Vietnam , 2015, Antimicrobial Agents and Chemotherapy.

[6]  P. Rathod,et al.  Antimalarial Drug Resistance: Literature Review and Activities and Findings of the ICEMR Network , 2015, The American journal of tropical medicine and hygiene.

[7]  C. Ascaso,et al.  Resistance of infection by Plasmodium vivax to chloroquine in Bolivia , 2015, Malaria Journal.

[8]  R. Maude,et al.  Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker , 2015, The Lancet. Infectious diseases.

[9]  John C. Tan,et al.  Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia. , 2015, The Journal of infectious diseases.

[10]  Gilean McVean,et al.  Genetic architecture of artemisinin-resistant Plasmodium falciparum , 2015, Nature Genetics.

[11]  F. Nosten,et al.  Pharmacokinetic Interactions between Primaquine and Pyronaridine-Artesunate in Healthy Adult Thai Subjects , 2014, Antimicrobial Agents and Chemotherapy.

[12]  Sue J Lee,et al.  Open-Label Crossover Study of Primaquine and Dihydroartemisinin-Piperaquine Pharmacokinetics in Healthy Adult Thai Subjects , 2014, Antimicrobial Agents and Chemotherapy.

[13]  L. Seidlein,et al.  Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis , 2014, The Lancet. Infectious diseases.

[14]  D. Kwiatkowski,et al.  Spread of artemisinin resistance in Plasmodium falciparum malaria. , 2014, The New England journal of medicine.

[15]  Patricia Tabernero,et al.  Mind the gaps - the epidemiology of poor-quality anti-malarials in the malarious world - analysis of the WorldWide Antimalarial Resistance Network database , 2014, Malaria Journal.

[16]  R. Haque,et al.  High prevalence of asymptomatic malaria in south-eastern Bangladesh , 2014, Malaria Journal.

[17]  B. Genton,et al.  A molecular marker of artemisinin-resistant Plasmodium falciparum malaria , 2013, Nature.

[18]  P. Kremsner,et al.  Antidogmatic approaches to artemisinin resistance: reappraisal as treatment failure with artemisinin combination therapy. , 2013, Trends in parasitology.

[19]  Andreas G. Nerlich,et al.  Molecular Identification of Falciparum Malaria and Human Tuberculosis Co-Infections in Mummies from the Fayum Depression (Lower Egypt) , 2013, PloS one.

[20]  N. White.  Counter Perspective: Artemisinin Resistance: Facts, Fears, and Fables , 2012, The American journal of tropical medicine and hygiene.

[21]  S. Parikh,et al.  Population Pharmacokinetics and Pharmacodynamics of Piperaquine in Children With Uncomplicated Falciparum Malaria , 2012, Clinical pharmacology and therapeutics.

[22]  K. Mate,et al.  Improving public health information: a data quality intervention in KwaZulu-Natal, South Africa. , 2012, Bulletin of the World Health Organization.

[23]  Alan D. Lopez,et al.  Global malaria mortality between 1980 and 2010: a systematic analysis , 2012, The Lancet.

[24]  T. Wellems,et al.  The threat of artemisinin-resistant malaria. , 2011, The New England journal of medicine.

[25]  E. Winzeler,et al.  Piperaquine Resistance Is Associated with a Copy Number Variation on Chromosome 5 in Drug-Pressured Plasmodium falciparum Parasites , 2011, Antimicrobial Agents and Chemotherapy.

[26]  A. Pain,et al.  Two nonrecombining sympatric forms of the human malaria parasite Plasmodium ovale occur globally. , 2010, The Journal of infectious diseases.

[27]  K. Silamut,et al.  Artemisinin resistance in Plasmodium falciparum malaria. , 2009, The New England journal of medicine.

[28]  M. Fukuda,et al.  Evidence of artemisinin-resistant malaria in western Cambodia. , 2008, The New England journal of medicine.

[29]  P. Garner,et al.  Antimalarial drug prescribing practice in private and public health facilities in South-east Nigeria: a descriptive study , 2007, Malaria Journal.

[30]  François Nosten,et al.  Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance. , 2007, The Lancet. Infectious diseases.

[31]  B. Uzochukwu,et al.  An in-depth study of patent medicine sellers' perspectives on malaria in a rural Nigerian community , 2006, Malaria Journal.

[32]  C. N. Chaulagai,et al.  Design and implementation of a health management information system in Malawi: issues, innovations and results. , 2005, Health policy and planning.

[33]  S. Hay,et al.  The global distribution of clinical episodes of Plasmodium falciparum malaria , 2005, Nature.

[34]  I. Hastings.  The origins of antimalarial drug resistance. , 2004, Trends in parasitology.

[35]  B. Sharp,et al.  Intercontinental Spread of Pyrimethamine-Resistant Malaria , 2004, Science.

[36]  P. Newton,et al.  Mixed-species malaria infections in humans. , 2004, Trends in parasitology.

[37]  Nicholas J White,et al.  Antimalarial drug resistance. , 2004, The Journal of clinical investigation.

[38]  N. White,et al.  Therapeutic responses to antimalarial and antibacterial drugs in vivax malaria. , 2004, Acta tropica.

[39]  John C. Wootton,et al.  Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum , 2002, Nature.

[40]  U. d’Alessandro,et al.  History and importance of antimalarial drug resistance , 2001, Tropical medicine & international health : TM & IH.

[41]  N. White,et al.  Antimalarial drug resistance and combination chemotherapy. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[42]  W. Ballou,et al.  Malaria in 1998: advances in diagnosis, drugs and vaccine development , 1998, Current opinion in infectious diseases.

[43]  N. White,et al.  Preventing antimalarial drug resistance through combinations. , 1998, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[44]  P. Olliaro,et al.  Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria. , 1996, Parasitology today.

[45]  K. Kain.  Chemotherapy and prevention of drug-resistant malaria. , 1995, Wilderness & environmental medicine.

[46]  S. Looareesuwan,et al.  HIGH RATE OF PLASMODIUM VIVAX RELAPSE FOLLOWING TREATMENT OF FALCIPARUM MALARIA IN THAILAND , 1987, The Lancet.

[47]  T. Harinasuta,et al.  The current status of drug resistance in malaria. , 1987, International journal for parasitology.

[48]  S. Teutsch,et al.  CHLOROQUINE-RESISTANT PLASMODIUM FALCIPARUM FROM EAST AFRICA: Cultivation and Drug Sensitivity of the Tanzanian I/CDC Strain from an American Tourist , 1979, The Lancet.

[49]  A. Hall,et al.  Amodiaquine resistant falciparum malaria in Thailand. , 1975, The American journal of tropical medicine and hygiene.

[50]  D. Mattingly,et al.  INTRACRANIAL HYPERTENSION AND STEROIDS. , 1964, Lancet.

[51]  Debono Ef.  OUTPATIENT WAITING TIME. , 1963 .

[52]  Organización Mundial de la Salud.  Guidelines for the treatment of malaria , 2010 .

[53]  L. Cong,et al.  Use and quality of antimalarial drugs in the private sector in Viet Nam. , 1998, Bulletin of the World Health Organization.

[54]  W. Wernsdorfer,et al.  The dynamics of drug resistance in Plasmodium falciparum. , 1991, Pharmacology & therapeutics.

[55]  P. Effersøe,et al.  Chloroquine-resistant Plasmodium falciparum malaria in Kenya. , 1979, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[56]  J. Lanier,et al.  Observations on two Plasmodium falciparum infections with an abnormal response to chloroquine. , 1961, The American journal of tropical medicine and hygiene.

[57]  W H TALIAFERRO,et al.  Acquired immunity in malaria. , 1948, Abstracts. International Congress on Tropical Medicine and Malaria.